InvestorsHub Logo
Followers 829
Posts 119609
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Thursday, 03/12/2015 10:06:26 AM

Thursday, March 12, 2015 10:06:26 AM

Post# of 2958
US payer contracts for V-Pak anticipate switch to 2nd-generation HCV regimen (ABT-493/ABT-530) when approved. (Source: ABBV’s Barclays webcast.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News